Long-term safety and efficacy of MBA-P01 for the treatment of glabellar lines: results from a multicenter, repeated-dose, open-label extension study

被引：0
|
作者：
Han, Hye Sung [1 ]
Kim, Won-Serk [2 ]
Lee, Yang Won [3 ]
Won, Chong Hyun [4 ]
Lee, Wooshun [5 ]
Choi, Sun Young [1 ]
Kim, Beom Joon [6 ]
机构：
[1] Chung Ang Univ, Coll Med, Dept Dermatol, Gwangmyeong Hosp, Anseong, Gyeonggi Do, South Korea
[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Dermatol, Seoul, South Korea
[3] Konkuk Univ, Sch Med, Dept Dermatol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Dept Dermatol, Asan Med Ctr, Seoul, South Korea
[5] Medytox Inc, Seoul, South Korea
[6] Chung Ang Univ, Chung Ang Univ Hosp, Dept Dermatol, Coll Med, Seoul, South Korea
来源：
JOURNAL OF DERMATOLOGICAL TREATMENT | 2024年 / 35卷 / 01期
关键词：
Glabellar lines; botulinum toxin; new botulinum toxin (MBA-P01); long-term safety; open-label extension study; TOXIN TYPE-A; BOTULINUM; PTOSIS; INJECTION;
D O I：
10.1080/09546634.2024.2418919
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Clinical trial registration information: This study is registered in ClincalTrials.gov (NCT05321979).
引用
收藏
页数：8
相关论文
共 30 条
  • [1] Long-Term Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines: Results From a 36-Month, Multicenter, Open-Label Extension Study
    Schlessinger, Joel
    Dover, Jeffrey S.
    Joseph, John
    Monheit, Gary
    Nelson, Diane B.
    Albright, Craig D.
    Axford-Gatley, Robert A.
    Cohen, Joel L.
    DERMATOLOGIC SURGERY, 2014, 40 (02) : 176 - 183
  • [2] Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, W. Rachel
    Pang, Yinuo
    Lee, Wan-Ju
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (12) : 2001 - 2010
  • [3] DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
    Fabi, Sabrina G.
    Cohen, Joel L.
    Green, Lawrence J.
    Dhawan, Sunil
    Kontis, Theda C.
    Baumann, Leslie
    Gross, Todd M.
    Gallagher, Conor J.
    Brown, Jessica
    Rubio, Roman G.
    DERMATOLOGIC SURGERY, 2021, 47 (01) : 48 - 54
  • [4] Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Pediatric Upper and Lower Limb Spasticity: Results From 2 Open-Label, Long-term Extension Trials
    Gormley, Mark
    Fehlings, Darcy
    Kim, Heakyung
    Bonikowski, Marcin
    Banach, Marta
    Gul, Fatma
    Meilahn, Jill
    Racette, Brad
    Huang, Nuoyu
    Niu, Xiaomeng
    James, Lynn M.
    Dimitrova, Rozalina
    JOURNAL OF CHILD NEUROLOGY, 2025, 40 (03) : 168 - 179
  • [5] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Stanley Cohen
    Jose L. Pablos
    Karel Pavelka
    Gerard Anton Müller
    Alan Matsumoto
    Alan Kivitz
    Hui Wang
    Eswar Krishnan
    Arthritis Research & Therapy, 21
  • [6] Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study
    Ketter, Terence A.
    Amchin, Jess
    Frye, Mark A.
    Gross, Nicholas
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 197 : 51 - 57
  • [7] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Cohen, Stanley
    Pablos, Jose L.
    Pavelka, Karel
    Mueller, Gerard Anton
    Matsumoto, Alan
    Kivitz, Alan
    Wang, Hui
    Krishnan, Eswar
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [8] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
    Santos, Raul D.
    Duell, P. Barton
    East, Cara
    Guyton, John R.
    Moriarty, Patrick M.
    Chin, Wai
    Mittleman, Robert S.
    EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
  • [9] Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study
    Fischer, Tanja
    Sattler, Gerhard
    Prager, Welf
    Rzany, Berthold
    Pavicic, Tatjana
    Gauglitz, Gerd
    Weissenberger, Petra
    Riaz, Shahbaz
    Kerscher, Martina
    JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (05) : 461 - 469
  • [10] Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
    Wu, Yan
    Fang, Fang
    Lai, Wei
    Li, Chengxin
    Li, Li
    Liu, Quanzhong
    Lu, Jianyun
    Pang, Xiaowen
    Sun, Jiaming
    Shi, Xiaofeng
    Picaut, Philippe
    Prygova, Inna
    Andriopoulos, Bill
    Sun, Qiuning
    AESTHETIC PLASTIC SURGERY, 2023, 47 (01) : 351 - 364
123